aod9604 clinical trial weight loss results kg or percent AOD-9604 Before and After: AOD-9604 and Smart Scales :
Description
B12 (cobalamin) supports red blood cell formation, nerve health, and the conversion of food into cellular energy

hydroxocobalamin injections are used for malabsorption or pernicious anaemia

Clinical studies typically assess outcomes at 4-week intervals, showing progressive fat loss throughout the study period

That is why oral AOD-9604 is best discussed as clinical-trial history, not as a direct substitute for current vial-based research planning
Long-Term Safety Considerations: While safety data from clinical trials spanning up to 24 weeks is reassuring, long-term safety data spanning years of continuous use remains limited

GLP-1 receptor agonists, such as semaglutide, complement this by suppressing appetite, improving insulin sensitivity, and promoting satiety, helping reduce calorie intake naturally
